Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SURF6 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | INO80D | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | CMC4 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | C16orf86 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | PRCP | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | CCNJ | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | C1orf131 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | YPEL4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | COA4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |